|
Name |
Dihexyl ether
|
Molecular Formula | C12H26O | |
IUPAC Name* |
1-hexoxyhexane
|
|
SMILES |
CCCCCCOCCCCCC
|
|
InChI |
InChI=1S/C12H26O/c1-3-5-7-9-11-13-12-10-8-6-4-2/h3-12H2,1-2H3
|
|
InChIKey |
BPIUIOXAFBGMNB-UHFFFAOYSA-N
|
|
Synonyms |
Dihexyl ether; 112-58-3; Hexyl ether; Hexane, 1,1'-oxybis-; N-Hexyl ether; 1-hexoxyhexane; DI-N-HEXYL ETHER; Ether, dihexyl; dihexylether; Bis(1-hexyl)ether; 1-(Hexyloxy)hexane; Bis(1-hexyl) ether; 1,1'-Oxybis(hexane); W1U07QA435; NSC-9286; NSC 9286; EINECS 203-987-8; BRN 1738177; hexylether; AI3-01454; MFCD00009525; Hexane,1'-oxybis-; 1-(hexyloxy)-hexane; Dihexyl ether, 97%; 1-(Hexyloxy)hexane #; EC 203-987-8; SCHEMBL66247; 4-01-00-01698 (Beilstein Handbook Reference); UNII-W1U07QA435; WLN: 6O6; DTXSID8059421; NSC9286; ZINC1699898; AKOS024390939; BS-23520; DB-041100; CS-0204272; FT-0625184; H0138; J-002797; Q63392163
|
|
CAS | 112-58-3 | |
PubChem CID | 8198 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 186.33 | ALogp: | 4.7 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 10 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 9.2 | Aromatic Rings: | 0 |
Heavy Atoms: | 13 | QED Weighted: | 0.447 |
Caco-2 Permeability: | -4.415 | MDCK Permeability: | 0.00002100 |
Pgp-inhibitor: | 0.03 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.001 | 20% Bioavailability (F20%): | 0.191 |
30% Bioavailability (F30%): | 0.45 |
Blood-Brain-Barrier Penetration (BBB): | 0.272 | Plasma Protein Binding (PPB): | 96.07% |
Volume Distribution (VD): | 1.633 | Fu: | 3.22% |
CYP1A2-inhibitor: | 0.841 | CYP1A2-substrate: | 0.366 |
CYP2C19-inhibitor: | 0.541 | CYP2C19-substrate: | 0.347 |
CYP2C9-inhibitor: | 0.374 | CYP2C9-substrate: | 0.47 |
CYP2D6-inhibitor: | 0.015 | CYP2D6-substrate: | 0.061 |
CYP3A4-inhibitor: | 0.104 | CYP3A4-substrate: | 0.079 |
Clearance (CL): | 9.645 | Half-life (T1/2): | 0.254 |
hERG Blockers: | 0.196 | Human Hepatotoxicity (H-HT): | 0.015 |
Drug-inuced Liver Injury (DILI): | 0.037 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.059 | Maximum Recommended Daily Dose: | 0.014 |
Skin Sensitization: | 0.919 | Carcinogencity: | 0.068 |
Eye Corrosion: | 0.972 | Eye Irritation: | 0.966 |
Respiratory Toxicity: | 0.218 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001127 | 0.860 | D05ATI | 0.448 | ||||
ENC000854 | 0.805 | D0Z5SM | 0.400 | ||||
ENC000855 | 0.667 | D0AY9Q | 0.339 | ||||
ENC000493 | 0.667 | D00FGR | 0.333 | ||||
ENC000473 | 0.659 | D00MLW | 0.315 | ||||
ENC000272 | 0.651 | D0XN8C | 0.315 | ||||
ENC001795 | 0.635 | D01QLH | 0.311 | ||||
ENC000261 | 0.632 | D07ILQ | 0.311 | ||||
ENC000742 | 0.612 | D05QNO | 0.308 | ||||
ENC000421 | 0.609 | D0Y8DP | 0.300 |